Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting Hepatic Stellate Cell Death to Reverse Hepatic Fibrosis
Xiangting Zhang, Yuan Zeng, Luying Zhao, et al.
Current Drug Targets (2023) Vol. 24, Iss. 7, pp. 568-583
Closed Access | Times Cited: 19

Showing 19 citing articles:

Targeting epigenetic and posttranslational modifications regulating ferroptosis for the treatment of diseases
Yumin Wang, Jing Hu, Shuang Wu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 77
Extracellular vesicles: emerging roles, biomarkers and therapeutic strategies in fibrotic diseases
Junyan Zhu, Sicong Wang, Dakai Yang, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 30
MafG/MYH9-LCN2 axis promotes liver fibrosis through inhibiting ferroptosis of hepatic stellate cells
Yalan Deng, Liqing Lu, Dandan Zhu, et al.
Cell Death and Differentiation (2024) Vol. 31, Iss. 9, pp. 1127-1139
Closed Access | Times Cited: 9
Autophagy and Senescence: The Molecular Mechanisms and Implications in Liver Diseases
Li Qiao, Yan Lin, Guangyu Liang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 16880-16880
Open Access | Times Cited: 18
Dietary intervention reverses molecular markers of hepatocellular senescence in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH
Mathias Flensted-Jensen, Denise Oró, Emma A. Rørbeck, et al.
BMC Gastroenterology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 7
Single‐cell RNA sequencing reveals reduced intercellular adhesion molecule crosstalk between activated hepatic stellate cells and neutrophils alleviating liver fibrosis in hepatitis B virus transgenic mice post menstrual blood‐derived mesenchymal stem cell transplantation
Lijun Chen, Yuqi Huang, Ning Zhang, et al.
MedComm (2024) Vol. 5, Iss. 8
Open Access | Times Cited: 6
Arctium lappa L. polysaccharides enhanced the therapeutic effects of nasal ectomesenchymal stem cells against liver fibrosis by inhibiting the Wnt/β-catenin pathway
Wen Xiang, Guoliang Yin, Haoming Liu, et al.
International Journal of Biological Macromolecules (2024) Vol. 261, pp. 129670-129670
Closed Access | Times Cited: 5
Heterogeneity of primary and metastatic CAFs: From differential treatment outcomes to treatment opportunities (Review)
Zixing Kou, Cun Liu, Wenfeng Zhang, et al.
International Journal of Oncology (2024) Vol. 64, Iss. 5
Open Access | Times Cited: 4
Ameliorative effects of sildenafil against carbon tetrachloride induced hepatic fibrosis in rat model through downregulation of osteopontin gene expression
Hend Elsayed Nasr, Ahmed Medhat Hegazy, Noha Osama El-Shaer, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Targeted delivery of polymeric NO-donor micelles to hepatic stellate cells for restoration of liver function and inhibition of hepatic fibrosis
Rui Yang, Lifen Yang, Ni Zhang, et al.
Journal of Controlled Release (2025) Vol. 379, pp. 466-477
Closed Access
Modulation of γδ T cells by USF3: Implications for liver fibrosis and immune regulation
Xianghong Wang, Rong Lin, Dehai Li, et al.
International Immunopharmacology (2025) Vol. 148, pp. 114100-114100
Closed Access
Natural Products as Modulators of Nrf2 Signaling Pathway: Potential Therapeutic Agents for Metabolic Associated Fatty Liver Disease
Xin-Nan Gu, Jinyu Zhang, Hao Ouyang, et al.
(2025)
Closed Access
Role of triggering receptor expressed on myeloid cells 2 in the pathogenesis of non-alcoholic fatty liver disease
Lihui Zhang, Sutong Liu, Qing Zhao, et al.
World Journal of Hepatology (2025) Vol. 17, Iss. 2
Closed Access
Fu-Gan-Hua-Xian Decoction Attenuates Liver Fibrosis via Circadian Clock Regulation
Zhenghua Xiao
Research Square (Research Square) (2025)
Closed Access
cPLA2α on the influence of Th17 and its role in the formation of liver fibrosis
Lina Ma, Wei Wang, Limin Gu, et al.
Cytotechnology (2025) Vol. 77, Iss. 3
Closed Access
Research Progress Regarding the Effect and Mechanism of Dietary Polyphenols in Liver Fibrosis
Jiayin Chang, Congying Huang, Siqi Li, et al.
Molecules (2023) Vol. 29, Iss. 1, pp. 127-127
Open Access | Times Cited: 9
Hepatoprotective Action Mechanism and Quantification of Soyasaponin Bb in Abri Herba by HPLC and Network Pharmacology
Xingmei Lin, Cheng‐Zhong Zhang, Baokang Huang
Journal of Ethnopharmacology (2024), pp. 118850-118850
Closed Access | Times Cited: 2
Multi-omics and experimental analysis unveil the key components in Scutellaria baicalensis Georgi to alleviate hepatic fibrosis via regulating cPLA2-mediated arachidonic acid metabolism
Yi Yang, Yi Liu, Yujie Cheng, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Mesenchymal stem cell therapy for liver fibrosis need “partner”: Results based on a meta-analysis of preclinical studies
Yan Xu, Xuesong Wang, Xiaolei Zhou, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 32, pp. 3766-3782
Open Access | Times Cited: 1
Page 1

Scroll to top